An overview of clinical experience with Solcoderm.
D000085:Acetates / Q000627:therapeutic use; D019342:Acetic Acid; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D003218:Condylomata Acuminata / Q000188:drug therapy; D003300:Copper / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007773:Lactates / Q000627:therapeutic use; D009506:Nevus / Q000188:drug therapy; D009566:Nitrates / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*; D014860:Warts / Q000188:drug therapy
D000085:Acetates; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D004338:Drug Combinations; D007773:Lactates; D009566:Nitrates; D003300:Copper; D019342:Acetic Acid